Related references
Note: Only part of the references are listed.The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty
Astrid Plamboeck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
Robert R. Henry et al.
DIABETES CARE (2013)
GLP-1 Receptor Is Expressed in Human Stomach Mucosa: Analysis of Its Cellular Association and Distribution within Gastric Glands
Efrat Broide et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
Michael A. Nauck et al.
DIABETES (2011)
Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies
S. S. C. Rao et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions
Gregory M. Holmes et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker et al.
LANCET (2008)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects
JJ Meier et al.
DIABETES (2005)
The gastrointestinal tract and glucose tolerance
A Vella et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans
S Quddusi et al.
DIABETES CARE (2003)
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a Physiologic meal in Type-II diabetic patients
S Gonlachanvit et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Share Paper
